Diana K Haggerty1, Rita S Strakovsky1, Nicole M Talge2, Courtney C Carignan1, Alicynne N Glazier-Essalmi3, Brooke R Ingersoll3, Rajendiran Karthikraj4, Kurunthachalam Kannan5, Nigel S Paneth2, Douglas M Ruden6. 1. Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI 48824, USA. 2. Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 48824, USA. 3. Department of Psychology, Michigan State University, East Lansing, MI 48824, USA. 4. Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA. 5. Department of Pediatrics, New York University School of Medicine, New York, NY 10016, USA. 6. Department of Ob/Gyn, Reproductive Endocrinology and Infertility, CS Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI, USA; Institutes for Environmental Health Science, Wayne State University School of Medicine, Detroit, MI, USA. Electronic address: douglasr@wayne.edu.
Abstract
BACKGROUND: Prenatal exposure to environmental chemicals has been associated with Autism Spectrum Disorder (ASD) symptoms in some, but not all, studies, but most research has not accounted for other childhood behavior problems. OBJECTIVES: To evaluate the specific associations of prenatal phthalate exposures with ASD symptoms in children (ages 3-6) accounting for other behavior problems, and to assess sex differences in these associations. METHODS: We measured phthalate metabolites in prenatal urine samples. Mothers completed the Social Responsiveness Scale-2nd edition (SRS-2) to assess child ASD symptoms and the Child Behavior Checklist (CBCL) to assess general behavior problems. We assessed associations of the sum of di-(2-ethylhexyl) phthalate metabolites, monobutyl phthalate, mono-isobutyl phthalate, and monoethyl phthalate (mEP) with ASD symptoms, adjusting for other behavior problems, using linear regression models (n=77). RESULTS: Most associations were null, and the sample size limited power to detect associations, particularly in the stratified analyses. After adjusting for internalizing and externalizing problems from the CBCL, ASD symptoms increased for each doubling of prenatal mEP concentration among boys only. CONCLUSIONS: Further investigation of maternal prenatal urinary phthalate metabolite concentrations and ASD symptoms while adjusting for other behavioral problems is warranted.
BACKGROUND: Prenatal exposure to environmental chemicals has been associated with Autism Spectrum Disorder (ASD) symptoms in some, but not all, studies, but most research has not accounted for other childhood behavior problems. OBJECTIVES: To evaluate the specific associations of prenatal phthalate exposures with ASD symptoms in children (ages 3-6) accounting for other behavior problems, and to assess sex differences in these associations. METHODS: We measured phthalate metabolites in prenatal urine samples. Mothers completed the Social Responsiveness Scale-2nd edition (SRS-2) to assess child ASD symptoms and the Child Behavior Checklist (CBCL) to assess general behavior problems. We assessed associations of the sum of di-(2-ethylhexyl) phthalate metabolites, monobutyl phthalate, mono-isobutyl phthalate, and monoethyl phthalate (mEP) with ASD symptoms, adjusting for other behavior problems, using linear regression models (n=77). RESULTS: Most associations were null, and the sample size limited power to detect associations, particularly in the stratified analyses. After adjusting for internalizing and externalizing problems from the CBCL, ASD symptoms increased for each doubling of prenatal mEP concentration among boys only. CONCLUSIONS: Further investigation of maternal prenatal urinary phthalate metabolite concentrations and ASD symptoms while adjusting for other behavioral problems is warranted.
Authors: Eric Rubenstein; Rebecca Edmondson Pretzel; Gayle C Windham; Laura A Schieve; Lisa D Wiggins; Carolyn DiGuiseppi; Andrew F Olshan; Annie G Howard; Brian W Pence; Lisa Young; Julie Daniels Journal: J Autism Dev Disord Date: 2017-10
Authors: Kristen Lyall; John N Constantino; Marc G Weisskopf; Andrea L Roberts; Alberto Ascherio; Susan L Santangelo Journal: JAMA Psychiatry Date: 2014-08 Impact factor: 21.596
Authors: John N Constantino; Sandra A Davis; Richard D Todd; Matthew K Schindler; Maggie M Gross; Susan L Brophy; Lisa M Metzger; Christiana S Shoushtari; Reagan Splinter; Wendy Reich Journal: J Autism Dev Disord Date: 2003-08
Authors: Joseph M Braun; Amy E Kalkbrenner; Allan C Just; Kimberly Yolton; Antonia M Calafat; Andreas Sjödin; Russ Hauser; Glenys M Webster; Aimin Chen; Bruce P Lanphear Journal: Environ Health Perspect Date: 2014-03-12 Impact factor: 9.031
Authors: Samuel Tanner; Sarah Thomson; Katherine Drummond; Martin O'Hely; Christos Symeonides; Toby Mansell; Richard Saffery; Peter D Sly; Fiona Collier; David Burgner; Eva J Sugeng; Terence Dwyer; Peter Vuillermin; Anne-Louise Ponsonby Journal: Antioxidants (Basel) Date: 2022-03-29
Authors: Rebekah L Petroff; Vasantha Padmanabhan; Dana C Dolinoy; Deborah J Watkins; Joseph Ciarelli; Diana Haggerty; Douglas M Ruden; Jaclyn M Goodrich Journal: Front Genet Date: 2022-03-31 Impact factor: 4.772